How to Sell Company and Pay No Tax: 4 Legal Strategies That Get You to Zero (2026)

The honest answer to how to sell company and pay no tax is that it is possible, but only through four specific Internal Revenue Code provisions used alone or stacked together: QSBS Section 1202, the ESOP Section 1042 rollover, a Qualified Opportunity Fund under Section 1400Z-2, and a Charitable Remainder Trust under Section 664. Each one has a hard qualification gate, a multi-year lead time, and a state-conformity wrinkle that can blow the plan up if the seller waits until the letter of intent arrives. Owners who start the conversation 24 to 60 months before a target close date routinely drop their effective federal tax rate from 23.8% to zero on deal sizes between $1M and $10M, and the math holds for larger transactions when the strategies are layered correctly.

What This Actually Means

“Pay no tax” is a specific, achievable outcome on a small to lower-middle-market business sale, not a marketing line. The Internal Revenue Code contains a small number of provisions that were written by Congress to encourage long-term capital formation, employee ownership, distressed-community investment, and charitable giving. Each one carries the explicit benefit of zero or deferred-to-zero capital gains tax when the qualification rules are met. The four covered below are the only ones that legitimately get a full sale to a zero federal tax outcome. Every other technique on the market either defers tax (Section 453 installment sale, Section 1031 exchange of real property) or reduces tax (Section 338(h)(10) election, Section 1060 asset allocation, residency relocation) but does not zero it out.

The trade-off in every case is time, qualification work, and structural complexity. QSBS requires a 5-year hold from original issuance. ESOP 1042 requires forming an ESOP, financing it, and reinvesting proceeds within 12 months. Opportunity Zones require holding the fund interest for 10 years. CRTs require giving up direct access to the principal in exchange for an annuity stream. None of these are last-minute moves. The seller who calls a tax advisor 60 days before close has roughly zero of these options available. The seller who started the planning 24 to 60 months out can stack two or three of them and bring effective tax to zero on the full sale.

One more honest framing: this is not aggressive tax planning. Every strategy below is in the Internal Revenue Code, has decades of regulatory history, and is routinely used by Big Four tax practices and AICPA-credentialed M&A tax counsel. The job is to know which combination fits the entity type, the cap table, the timeline, the state of residency, and the owner’s post-close goals. The cost of getting it right (typically $10K to $50K in tax counsel fees) is a rounding error against the $500K to $2M of tax that the right structure saves on a mid-seven-figure deal.

The 4 Strategies That Get You to Zero

1. QSBS Section 1202: 100% Federal Exclusion Up to $10M

Current state: The seller holds C-corporation stock that was issued at original issuance (not bought on a secondary market), has been held for at least 5 years, and was issued at a time when the company’s aggregate gross assets were under $50M. Target state: File Form 8949 with the Section 1202 exclusion claimed against the gain on sale. Impact on outcome: Exclude up to the greater of $10M per shareholder or 10x the seller’s basis in the stock, from federal capital gains tax. On a $5M sale of qualifying QSBS held for 7 years with $500K of basis, the entire $4.5M gain is excluded. Federal tax owed: zero.

QSBS (Qualified Small Business Stock) under IRC Section 1202 is the single highest-impact provision in the Code for founders of C-corp operating businesses. The 100% exclusion was made permanent by the Tax Cuts and Jobs Act for stock acquired after September 27, 2010, and the cap is per-shareholder, meaning a founding team of three each gets their own $10M exclusion. The hard requirements are strict: the issuer must be a domestic C-corp from inception (an LLC or S-corp converted to a C-corp does not qualify for the time before conversion), the stock must be acquired at original issuance for cash, property, or services, the company must have had aggregate gross assets of $50M or less at all times through and immediately after issuance, and at least 80% of the corporation’s assets must be used in an active trade or business that is not in an excluded field.

The excluded fields under Section 1202(e)(3) are the trap that kills more QSBS planning than anything else. The list includes any trade or business involving the performance of services in the fields of health, law, engineering, architecture, accounting, actuarial science, performing arts, consulting, athletics, financial services, brokerage services, or any trade or business where the principal asset is the reputation or skill of one or more employees. Banking, insurance, financing, leasing, investing, farming, mineral extraction, hotels, motels, and restaurants are also excluded. Software, technology, biotech, manufacturing, and most product-based businesses qualify cleanly. Professional services firms and consulting boutiques usually do not.

State conformity is the second trap. California (R&TC Section 18152) does not conform to Section 1202 and taxes the full gain at the 13.3% top rate. Pennsylvania, Mississippi, New Jersey, and Alabama also do not conform. Massachusetts conforms partially. Most other states (including Texas, Florida, Nevada, Washington, and the other no-income-tax states) either conform fully or have no state income tax. The play for a California-based founder with qualifying QSBS is to establish bona fide residency in a no-income-tax state at least 12 to 18 months before close, which is covered later in the worked example.

2. ESOP Section 1042 Rollover: Indefinite Deferral That Becomes Zero at Death

Current state: The seller owns C-corporation stock (or is willing to convert from S-corp to C-corp and wait the required 5 years), the company has at least 30 employees who can absorb beneficial ownership, and EBITDA is at least $3M to support the financing structure. Target state: Sell at least 30% of the company stock to a newly formed Employee Stock Ownership Plan and, within 12 months of the sale, reinvest the proceeds into Qualified Replacement Property (QRP, generally US operating-company stocks or bonds). Impact on outcome: All capital gains tax on the ESOP-sold stock is deferred indefinitely under IRC Section 1042. If the QRP is held until the seller’s death, the basis steps up under Section 1014 and the deferred gain is eliminated entirely. Net federal tax owed across the seller’s lifetime: zero.

The Section 1042 rollover is the most elegant zero-tax structure in the Code because it pairs a current deferral with a step-up at death that wipes the deferred gain out completely. The mechanics work like this: the seller sells the C-corp stock to the ESOP at fair market value (determined by an independent ERISA appraisal), the ESOP pays the seller in cash funded by a combination of bank debt and a seller note, and the seller reinvests the proceeds into a portfolio of US operating-company stocks or bonds within the 12-month replacement window. The basis in the original C-corp stock carries over to the QRP. As long as the QRP is held, the deferral continues. When the seller dies, Section 1014 steps the basis up to fair market value, and the family inherits the QRP with no embedded capital gains tax.

The ESOP installation takes 12 to 18 months and requires an ERISA-credentialed ESOP trustee, an independent business appraisal, tax counsel for the Section 1042 election, employee benefits counsel for the plan document, a lender for the senior debt tranche, and Department of Labor compliance review. The total advisory cost runs $200K to $500K on a $10M to $50M deal. The trade is that the seller takes a price discount of 5% to 15% versus a third-party strategic sale, in exchange for indefinite tax deferral, the option to keep operating the business, and the legacy outcome of employee ownership. For founders with no obvious strategic buyer and a workforce they want to reward, ESOP 1042 routinely produces the highest after-tax outcome of any exit structure.

If the seller currently runs an S-corp, the entity must convert to C-corp status and the seller must hold the converted stock for at least 5 years before the Section 1042 sale to the ESOP. This is one of the rules that makes ESOP planning a multi-year project, not a last-minute pivot. The QRP itself has constraints: no mutual funds, no real estate, no foreign securities, no government bonds, and no stock of the company being sold. Most sellers build a diversified US large-cap and corporate bond portfolio through a wirehouse or RIA that has done QRP work before.

3. Qualified Opportunity Zone Funds Under Section 1400Z-2

Current state: The seller has just recognized a capital gain on the sale of their business and is within the 180-day reinvestment window. Target state: Contribute some or all of the gain to a Qualified Opportunity Fund (QOF) and file Form 8997 with each year’s tax return. Impact on outcome: Defer recognition of the contributed gain until December 31, 2026 (or 2027 under current statutory extensions), and after 10 years inside the QOF, all new appreciation on the fund interest is permanently tax-free. The original gain is taxed on the deferral end date, but every dollar of QOF growth above the contributed basis comes out at zero tax.

The Opportunity Zone program under IRC Section 1400Z-2 was created by the Tax Cuts and Jobs Act in 2017 and is the most flexible deferral tool available for sellers who want to keep capital working in real assets after a business sale. The 180-day clock starts on the date the gain is recognized (the closing date for cash deals, the date of installment-note payments for Section 453 deals). The QOF must hold at least 90% of its assets in Qualified Opportunity Zone Property (QOZP), which can be tangible property used in a trade or business in a designated census tract, or equity in a Qualified Opportunity Zone Business (QOZB) that meets the 70% tangible property test.

The “pay no tax” outcome through OZ requires careful sequencing. The original gain from the business sale is still taxed in 2026 (or whenever the statutory deferral date lands). What becomes tax-free is the second-layer gain that builds inside the QOF over the 10-year hold. A typical scenario: a founder sells for $8M of gain, rolls $5M into a QOF that develops commercial real estate in a designated tract, and pays federal tax on the $5M of original gain in 2026. If the QOF interest grows to $12M over 10 years, the $7M of new appreciation comes out at zero federal tax. The structure does not eliminate the first layer of tax; it eliminates all subsequent layers. Combined with QSBS or 1042 on the original sale, the entire chain (original gain plus all future appreciation) can land at zero.

The IRS has issued final regulations clarifying the 90% asset test (measured semi-annually), the 70% tangible property test for QOZBs, the substantial improvement requirement (must double the basis of acquired tangible property within 30 months), and the working capital safe harbor that gives QOZBs up to 31 months to deploy committed capital. The Tax Cuts and Jobs Act extension passed in 2025 expanded the program’s runway, but planners should monitor legislative developments because the deferral end date and the basis step-up percentages have been adjusted multiple times since the original 2017 enactment.

4. Charitable Remainder Trust Under Section 664

Current state: The seller has charitable intent, wants tax-deferred income for life or for a term of years, and is willing to give up direct access to the principal in exchange for a tax-favored annuity stream. Target state: Contribute the appreciated business interest into a properly drafted CRT (Charitable Remainder Trust under IRC Section 664) before signing the purchase agreement or any binding letter of intent. The CRT then sells the business interest with zero capital gains tax inside the trust. Impact on outcome: The CRT pays no tax on the sale. The seller receives an immediate charitable income tax deduction equal to the present value of the remainder interest (typically 10% to 35% of the contributed value). The CRT pays the seller a fixed annuity or unitrust amount for up to 20 years or for life, taxed as it is received under the four-tier ordering rules.

The CRT is the only one of the four strategies that can be installed within a few months of close, but the timing rules are strict. The contribution to the CRT must precede any binding sale commitment. If the seller has already signed a letter of intent, executed a purchase agreement, or otherwise locked in a buyer at a price, the IRS will collapse the transaction under the assignment-of-income doctrine and tax the gain to the seller personally as if the CRT contribution never happened. The case law on this is unforgiving (Ferguson v. Commissioner, 174 F.3d 997, 9th Circuit 1999). The contribution has to happen at a stage where the sale is still genuinely contingent.

The CRT pairs cleanly with QSBS or 1042 on a partial-contribution basis. A seller contributing $2M of a $10M sale into a 20-year Charitable Remainder Annuity Trust gets roughly $300K to $500K of immediate deduction value (offsetting other income in the year of sale), defers tax on the $2M gain across the annuity payment term, and ends up with comparable lifetime after-tax cash flow versus paying tax upfront on the full $10M. The remainder beneficiary (a public charity, a private foundation, or a donor-advised fund the seller controls) receives whatever is left in the trust at termination. Sellers without charitable intent should not use CRTs; the structure only pencils out when the charitable remainder has independent value to the seller’s family or legacy plan.

Worked Example: A $5M QSBS Software Company Sale

Consider a fictional but realistic scenario. Maria founded a B2B software company in 2019, incorporating directly as a Delaware C-corp on day one. She funded the business with $500K of cash equity (her basis). The company grew profitably, never raised outside capital, and never exceeded $50M in gross assets. Maria held the stock for 7 years. In 2026, a strategic acquirer offered $5M for 100% of the equity. Maria’s gain on sale: $4.5M ($5M sale price minus $500K basis).

Scenario A: No planning, California resident. Federal capital gains tax at the 20% rate plus the 3.8% net investment income tax: $4.5M times 23.8% equals $1.07M federal tax. California state tax at the 13.3% top marginal rate: $4.5M times 13.3% equals $598K state tax. Total tax owed: $1.67M. Net to Maria: $3.33M from a $5M sale (33% tax rate all-in).

Scenario B: QSBS claimed, California resident. QSBS Section 1202 exclusion: the lesser of $10M or 10x basis ($5M). Since the gain of $4.5M is below the $5M cap, the entire gain is federally excluded. Federal tax owed: zero. California does not conform to Section 1202 (R&TC Section 18152), so California state tax of $598K is still owed. Total tax: $598K. Net to Maria: $4.40M (12% all-in). Tax savings versus Scenario A: $1.07M.

Scenario C: QSBS claimed, Texas resident (relocated 24 months before close). Federal exclusion under QSBS: full ($4.5M gain excluded). Texas has no state income tax. Total tax owed: zero. Net to Maria: $5.0M. This is the true zero-tax outcome. Tax savings versus Scenario A: $1.67M. The pre-sale residency move (selling the California home, establishing Texas domicile, satisfying the 183-day physical presence rule, changing voter registration, drivers license, doctors, and bank accounts) is what closes the conformity gap.

Scenario D: QSBS plus CRT on the marginal portion. Maria contributes $1M of stock into a 20-year CRT before signing the LOI. The CRT sells that $1M of stock with zero capital gains tax. Maria takes an immediate $200K charitable deduction (offsetting other 2026 income at her ordinary rate). The remaining $4M of stock sells with QSBS exclusion claimed. As a Texas resident: zero federal tax on the $3.6M gain ($4M minus $400K pro-rata basis). The CRT pays Maria a $60K annual annuity for 20 years (the principal compounding inside the trust at trust-level returns). Total upfront tax: zero. Lifetime tax on annuity payments: spread across 20 years at favorable four-tier ordering. Charitable remainder at trust termination: roughly $1.2M to $1.8M to her donor-advised fund. This is the layered approach that turns a $5M sale into a zero-current-tax outcome with a built-in charitable legacy.

The lesson from the four scenarios: the same $5M sale produces wildly different after-tax outcomes depending on entity choice (must be C-corp from inception for QSBS), holding period (5+ years), residency (no-conformity state versus no-income-tax state), and the optional CRT layering. Each one of those decisions was made years before the offer arrived. None of them could be installed in the final 60 days.

Common Mistakes That Kill the Zero-Tax Outcome

Converting an LLC or S-corp to C-corp Too Late

QSBS only counts the holding period from the date the C-corp stock was issued. An LLC that converts to a C-corp in 2026 and sells in 2028 has held qualifying C-corp stock for 2 years, not the required 5. The years the business operated as an LLC or S-corp do not count toward the QSBS holding period. The conversion must happen at least 5 years before the target close date, and the conversion itself triggers a non-taxable Section 351 exchange where the asset basis carries into the new C-corp. Founders considering QSBS need to convert as early in the business lifecycle as possible, ideally at inception.

Triggering Assignment of Income on a CRT Contribution

The CRT structure collapses entirely if the contribution happens after a binding commitment to sell. The IRS and the courts have consistently held that once the seller has accepted an offer, signed an LOI, or otherwise committed to a transaction, contributing the asset to a CRT does not shift the gain. The gain is already economically owned by the seller. The CRT contribution must happen at a stage where the sale is still genuinely contingent (no LOI signed, no binding price, no escrow opened). Most M&A tax counsel recommend completing the CRT contribution at least 30 to 60 days before the LOI is signed.

Failing California Residency Audits

The California Franchise Tax Board runs aggressive residency audits on high-net-worth sellers who move to no-income-tax states in the year of a major liquidity event. The FTB looks at physical presence (the 183-day test), location of family members, location of the seller’s primary residence, drivers license, voter registration, doctors, dentists, club memberships, vehicle registrations, where mail is delivered, and where the seller’s professional and personal life is actually conducted. Sellers who keep a California house “for the grandkids” and visit twice a quarter routinely lose the audit. Sellers who fully relocate, sell or convert the California house, register all aspects of their life in the new state, and document the move with intent letters and personal records routinely win. The move needs to happen at least 12 to 18 months before close.

Failing the QSBS Excluded-Field Test

Many founders assume their tech-adjacent or services-adjacent company qualifies for QSBS without checking the excluded-field list. Consulting firms, financial advisory practices, accounting firms, law firms, medical practices, dental practices, performing-arts companies, athletic-services companies, banking and insurance operations, hotels, motels, restaurants, farming operations, and mineral-extraction businesses are all excluded. A software-as-a-service company that delivers a software product clearly qualifies. A software-as-a-service company whose value is primarily the founder’s consulting and customization labor probably does not. Tax counsel should be asked for a written QSBS qualification memo at least 12 months before the target close date.

Believing “Monetized Installment Sale” Pitches

The IRS issued formal guidance in 2023 designating certain “monetized installment sale” transactions as listed transactions, meaning they are presumed to be abusive tax shelters with mandatory disclosure requirements (IRS Rev. Rul. 2024-15 and related notices). These structures, often marketed by aggressive promoters, claim to combine a Section 453 installment sale with a back-to-back loan against the installment note to give the seller both immediate cash and indefinite tax deferral. The IRS has rejected this combination. Any advisor pitching a monetized installment sale, a “deferred sales trust” with characteristics matching the listed-transaction criteria, or any other “guaranteed zero tax” product without a clear basis in published IRC sections should be declined and reported to the seller’s primary tax counsel.

Missing the 180-Day OZ Reinvestment Window

The Opportunity Zone deferral requires the gain to be reinvested into a QOF within 180 days of the date the gain is recognized. For a cash sale closing on July 1, the deadline is December 28 of the same year. Sellers who close in December often run out of calendar to do proper QOF due diligence, leading to rushed allocations into funds with questionable underwriting. The fix is to start QOF diligence 60 to 90 days before close so the reinvestment is queued up and ready to fund on the day after wire receipt.

The Timeline: When to Start Each Strategy

1. 60+ months before close: Incorporate or convert to a Delaware C-corp if QSBS is the target strategy. Issue founder stock at original issuance with documented basis. Verify the company is in a qualifying field under Section 1202(e). This is the earliest possible action and the one that produces the largest tax benefit.
2. 36 to 60 months before close: If considering ESOP 1042, evaluate the workforce, the EBITDA stability, and the financing capacity. Begin informal conversations with ESOP trustees and lenders. If currently an S-corp, model the conversion timing and the 5-year hold requirement post-conversion.
3. 24 to 36 months before close: If considering a residency move, sell or convert the high-tax-state primary residence, establish bona fide domicile in a no-income-tax state, satisfy the 183-day physical presence test, and document the move with intent letters and personal record changes. Engage a residency-defense law firm to pre-vet the audit risk.
4. 12 to 24 months before close: Engage M&A tax counsel for a written QSBS qualification memo. Engage an ESOP trustee and start the formal feasibility study if ESOP is the chosen path. Begin charitable planning conversations with an estate attorney and a charitable advisor if CRT is contemplated.
5. 6 to 12 months before close: Install the chosen primary structure. For ESOP, this is the trustee engagement, the ERISA appraisal, the financing commitment, and the plan document drafting. For CRT, this is the trust formation and the asset contribution (which must precede any binding LOI).
6. 0 to 6 months before close: Negotiate the LOI and purchase agreement with the chosen structure baked into the deal terms. For QSBS, this means preserving the C-corp stock-sale treatment. For ESOP, this means coordinating the ESOP purchase price with the third-party offer. For CRT, this means confirming the CRT contribution is complete and recorded before LOI signature.
7. At close: Recognize the gain (or contribute it to the CRT, or sell to the ESOP and fund the QRP within 12 months). For QOF, mark the recognition date as day one of the 180-day reinvestment window.
8. Post-close: File Form 8949 with QSBS exclusion, Form 8023 for any Section 338(h)(10) elections, Form 8997 annually for QOF, and the personal income tax return reflecting the CRT contribution deduction. Hold QRP indefinitely for ESOP 1042. Hold QOF interest for 10 years to lock in the appreciation exclusion.

How CT Acquisitions Approaches This

CT Acquisitions works as a sell-side advisor on lower-middle-market deals where tax structure is part of the deal architecture, not an afterthought. The work starts with a free consultation that maps the seller’s entity type, holding period, state of residency, and post-close goals against the four zero-tax strategies. If QSBS is viable, the deal structure is built around preserving the C-corp stock-sale treatment that the exclusion requires. If ESOP is the chosen path, CT coordinates with the ESOP trustee, the lender, and the seller’s tax counsel to time the Section 1042 election correctly.

The CT model is buyer-paid. The seller does not pay an advisory fee out of pocket. CT’s compensation comes from the buyer-side success fee, which means CT is structurally aligned with maximizing the seller’s after-tax outcome rather than chasing a percentage of headline price. For owners of qualifying QSBS companies, ESOP-candidates, and any sale where tax structure materially affects net proceeds, the CT process is designed to coordinate with the seller’s existing tax counsel and turn the structural levers into real dollars.

Frequently Asked Questions

Is it really legal to sell a company and pay zero federal tax?

Yes, when the seller qualifies for QSBS Section 1202, the entire federal capital gains tax on up to $10M (or 10x basis) of gain is excluded by statute. The exclusion is a deliberate policy choice by Congress to encourage long-term investment in small C-corp operating businesses. The same is true for Section 1042 ESOP rollovers held until death (Section 1014 step-up), Section 1400Z-2 Opportunity Zone gains held 10+ years, and CRT contributions properly executed before a binding sale. All four are explicit Code provisions with decades of regulatory and case-law support.

Can I do this if I am structured as an LLC or an S-corp?

Not directly. QSBS requires C-corp stock issued at original issuance, so an LLC or S-corp must convert to a C-corp and the founder must hold the new C-corp stock for at least 5 years before the sale. Section 1042 ESOP rollovers also require C-corp stock; an S-corp must convert and hold for 5 years. CRTs and Opportunity Zone funds work with any entity type as long as the gain is a capital gain on a sale of business interests or assets. The entity-conversion timing is what makes these multi-year planning projects, not last-minute moves.

What if my business is in an excluded field for QSBS?

If the business is in a Section 1202(e)(3) excluded field (consulting, professional services, financial services, hospitality, real estate, mining, banking, insurance), QSBS is not available and a different combination of strategies has to carry the load. ESOP 1042 works for excluded fields as long as the entity is C-corp and has enough employees. CRTs work for any asset type. Opportunity Zones work for any capital gain. A combination of ESOP 1042 plus partial CRT plus residency relocation can still produce a zero or near-zero current-tax outcome for an excluded-field business.

How much does it cost to set up these structures?

Tax counsel fees typically run $10K to $50K for a QSBS qualification memo and deal-structure coordination. ESOP installations cost $200K to $500K all-in (trustee, appraisal, ERISA counsel, lender fees, plan document). CRT formation runs $5K to $20K in attorney fees. QOF investments carry the fund’s own management fees (1% to 2% annual) plus the underlying real estate or business diligence costs. The total upfront cost on a fully stacked structure can run $250K to $600K, which is a rounding error against the $500K to $2M of tax savings the structure typically generates on a mid-seven-figure deal.

What is the IRS audit risk on these strategies?

The audit risk is low when the structures are installed correctly and well documented. QSBS, ESOP 1042, and Opportunity Zones are all explicit Code provisions with detailed regulations, and the IRS has well-established review procedures. CRTs are highly regulated under Section 664 and the supporting Treasury regulations. The audit risk is high only when sellers use aggressive variants pitched by promoters (monetized installment sales, deferred sales trusts marketed as Section 453 plus loan combinations, abusive captive insurance structures). The IRS has designated several of these as listed transactions in 2023 and 2024, meaning mandatory disclosure and high audit probability.

Can I combine multiple strategies on one sale?

Yes, and the layered approach is often the highest-return play. A common stack on a $10M sale: QSBS exclusion on the first $5M of gain (zero federal tax), CRT contribution of $2M of stock before the LOI (zero current tax plus deduction value), and Opportunity Zone reinvestment of any residual taxable gain (deferral to 2026 plus tax-free appreciation after 10 years). With a pre-sale residency move to a no-income-tax state, the entire $10M sale can land at zero current federal and state tax with a built-in charitable legacy and long-term tax-free real estate appreciation.

What to Do Next

Selling a company and paying no tax is achievable, but only for owners who start the planning conversation years ahead of the close date. The first practical step is a free consultation where the entity structure, the holding period, the state of residency, and the operating-field qualification can be mapped against the four strategies. The conversation does not commit the seller to any structure, any timeline, or any fee. It surfaces which of the four zero-tax paths is realistic given the current facts, and what calendar action needs to happen first.